.Merck trumps profits requirements, rears sales expectation on strong need for leading drugs like Keytruda CNBCMerck & Co. (MRK United States) Trumps Income Projections as Keytruda Sales Increase BloombergMerck Inventory: Pharma Giant Posts Sturdy End Results, However Overview Drops Short Real estate investor's Business DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck defeats income and purchases desires among Keytruda asset, yet gives blended full-year expectation MarketWatch.